BLUE TOE SYNDROME

This adverse event was reported 392 times

These drugs are most commonly taken by patients reporting BLUE TOE SYNDROME:

# Drug Count
0 WARFARIN 57
1 METOPROLOL TARTRATE 41
2 METOPROLOL 37
3 PREDNISONE 35
4 ASPIRIN 33
5 ASPIRIN 325 MG 33
6 ASPIRIN 81 MG 33
7 METOPROLOL TARTRATE INJECTION 33
8 WARFARIN SODIUM 30
9 ACETAMINOPHEN 29
See all common drugs associated with BLUE TOE SYNDROME

BLUE TOE SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TAGRAXOFUSP 2 0.0037
1 DALTEPARIN SODIUM 22 0.0021
2 DIMENHYDRINATE 22 0.0021
3 BODY CLEANSER 1 0.0014
4 LEVOKETOCONAZOLE 1 0.0013
5 DIFLUNISAL 1 0.0012
6 DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG 1 0.0012
7 DISOPYRAMIDE PHOSPHATE 1 0.0012
8 CHLOROTHIAZIDE SODIUM 1 0.0011
9 NISOLDIPINE 1 0.0008
See all drugs enriched for association with BLUE TOE SYNDROME

BLUE TOE SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD123 Interaction [EPC] 2 0.0037
1 Sclerosing Agent [EPC] 1 0.0022
2 Cortisol Synthesis Inhibitor [EPC] 1 0.0013
3 Blood Viscosity Reducer [EPC] 3 0.0007
4 Phosphodiesterase 3 Inhibitor [EPC] 3 0.0005
5 alpha-1 Adrenergic Agonist [EPC] 2 0.0005
6 Complement Inhibitor [EPC] 21 0.0004
7 Calcitonin [EPC] 1 0.0003
8 Vitamin D2 Analog [EPC] 2 0.0003
9 Anti-coagulant [EPC] 1 0.0003
See all drug classes enriched for association with BLUE TOE SYNDROME